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ABS TRAC T

Phenotypic Profiles of Lymphocytes in Adult C57BL/6N
Mice Inf ected with Cryptosporidium parvum
by
Diane R. Bienek, Master of Science
Utah State University, 1994
Major Professor : Dr. Mark c . Healey
Department: Biology
The purpos e of this study was to quan ti tate the
populations o f lymphocytes in the s pleens and intestines of
normal and immunosuppressed adult C57BL/6N mice that were
noninfected or inf ected with Cryptosporidi um parvum.

This

was accomplished by using the following methodologies:
immunohistochemistry, ELISA-spot assay, and fl ow cytometry .
Mice in groups 1 and 2 were immunosuppressed, but only
group 2 was in fecte d.

Mice in group 3 we re only infected,

whereas group 4 served as the normal cont rol .

Mice were

immunosuppressed with dexamethasone (DEXI at a dosage of
125 ~g / mouse/day.

Inf ected mice received 106 oocysts per os .

The numbers o f lymphocytes were monitored fr om day 0 to day
18 postinfect i on.

Flow cytometry using antibodies directed

against CD4+ and CDS+ T cells (helper and cytotoxic,
respectively) and B cells (expressing IgG, IgM, and IgA
receptors) revealed that

c.

parvum did not evoke an
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alteration in the phenotypic profile of lymphocytes within
spleens or Peyer's patches (PP) of mice in groups 2 and 3
that was statist i cally different from groups 1 and 4.
Immunosuppressed mice (groups 1 and 2) had signifi cantly
fewer lymphocytes (bearing CD4+, IgG, IgM, and IgA receptors) within the spleen when compared with mice in groups 3
and 4 (P<0.05) .

Splenic leucocytes expressing macrophage

(CDllb) and CD8+ recept ors failed to respond to DEX.
Moreover, the CD4+ to CD8+ cell ratio was decreased in the
spleens of immunosuppressed mice .

After 6 days of DEX

administration , the percentage of T cells (CD8+) and
macrophages within the PP was significantly higher than
nonimmunosuppressed mice (P<0.05).

Administration of DEX

had no apparent effect on B (beari ng IgG, IgM, and IgA
receptors) and T lymphocytes (CD4 +) present within the PP.
However, DEX treatment was associated with a lower CD4+ to
CD8+ lymphocyte ratio within the PP.

Preliminary studies

using immunohistochemistry demonstrated that lymphocytes
bearing IgA receptors are significantly less in mice that
receive d DEX for 20 days (P<0.05), whereas the number of IgG
and IgM receptor - bearing lymphocytes was not signif-icantly
affected.
(101 pages)

INTR ODUCTI ON

Cryptosporidium parvum is a protozoan parasite with

worldwide distribution that infects humans and other
vertebrates.

Depending on the species and isolate of the

parasite and the age and immunologic status of the host,
the severity of infection can range from subclinical to
severe (41) .

Cryptosporidiosis in immunocompromised

patients (particularly those with acquired immunodeficiency
syndrome {AIDS}) presents with a prolonged , life threatening, debilitating diarrhea.

Clinical disease frequently

includes weight loss, fever, abdominal pain, and occasionally hematogenous spread to extraintestinal sites (49,
132).

C. parvum is a frequent cause of illness in immuno-

competent individuals .

These infections often present with

a self-limiting diarrhea and are usually accompanied by
abdominal cramps.

These observations suggest that the

host's immune status does not appear to affect susceptibility of humans to c . parvum infections (34) .

However, the

marked d i fferences in the outcomes between immunocompromised and immunocompetent persons infected with C. parvum
may be explained by the development of a sufficient immune
response to clear the parasite from the intestinal mucosa .
No consistently effective chemotherapeutic agent
against

c.

parvum is available.

The literature indicates

that an acquired immune response is necessary to overcome
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cryptosporidial infections.

Therefore, immunoprophylactic

and immunomodulation therapies should be able to prevent
and treat cryptosporidiosis.

A prerequisite to successful

immunological intervention is a thorough unde rstanding of
the immune mechanisms responsible for arresting the development of this coccidian parasite.

Previous studies have

shown that cryptosporidial infection results in the appearance of fecal and serum antibodies chat are specific to c.
parvum.

Although marked seroconversion occurs during or

soon after recovery from intestinal cryptosporidiosis, it
is not known if these antibodies play a role in protective
immunity.

Furthermore, the coproantibod ies and serum

response may not reflect the concentration or isotype of
antibody available at the site of infection (69).

Very

little is known about the cell-mediated immune response
within the intestinal lamina propria or the Peyer's patches
( PP ) of individuals infected with C. parvum.
Before addressing the immunobiology of c. parvum, a
treatise of chis complex protozoan paras ite is presented.
Such an account affords a better underst anding of the
immunobiology of the host-parasite relationship.
Purpose

of

this

research

The purpose of this research was to quantify the
subpopulations of T and B lymphocytes and M0 (macrophages
expressing CDllb receptors) in the spleens and intestines
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of i mmunocompetent and immunosuppressed adult C57BL / 6N mice
with cryptosporidi osis .
Objecti v e s

Three objectives were designed to characterize the
kinet ics and phenotypic profiles of lymphocytes in adult
C57BL / 6N mice infected with C. parvum.

These objectives

included:
1)

Quantify the populations o f lymphoid cells present

in the spleens and small intestines of normal and immuno suppressed adult C57BL / 6N mice that were either infected or
uninfected with c. parvum.

Subsequently , determine the

expression levels of these cells from day 0 to day 18
postinfection (PI).
2)

Co rrelate oocyst shedding intensities with the

expression o f these lymphoid populations.
3)

Qua ntify the populations o f B lymphocytes (ex-

pressing immunoglobulin ( Ig} G, M, and A receptors) present
in the termina l ilea and spleens of mice infected with C.

parvum using immunofluorescence techniqu es on tissue
sections.
This research effort was undertaken to provide an
understanding of the splenic and intestinal immune
mechanisms that devel op in response t o C. parvum infections
and dexamethasone (DEX ) immunosuppression.

Moreover, this

research will serve as a first step toward devel op ing

4

immunomodulation therapies for use in patiencs wich debili tacing cryptosporidiosis.
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LITERATURE

REVIEW

History

Crypcosporidium parvum is a protozoan assigned to the

phylum Apicomplexa, class Sporozoasida, order Eucoccidiorida, and family Cryptosporidiidae that was identified and
named in 1912 by Ernest E. Tyzzer (133).

For nearly 50

years after Tyzzer's work, C. parvum was regarded as a
commensal of no economical or medical importance .

In-

creased vete rinary investigation of Cryptosporidium began
in the early 1970's, when it was discovered to be associated with severe bovine diarrhea (104) .

In 1976, Cryp-

tosporidium was first reported as a human pathogen in an

immunocompetent 3-year-old girl with acute enteritis who
recovered spontaneously (102) .

After that, relatively few

cases were subs equently reported until 1982, when the
Center for Disease Control received reports that 21 males
had protracted diarrhea caused by Crypto sporidium in
association with AIDS .

Medical and veterinary interest in

the epidemiology, diagnosis, treatment , and prevention
increased substantially thereafter throughout the world
(41) .
Life

cycle

and

epidemiology

The life cycle of C. parvum is illustrated in Fig. 1 .
Infection of a new host occurs when thick - walled oocysts in
food, water , or the general environment are ingested or
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FIG. 1.
Life Cycle of Cryptosporidium parvum.
Infection
of a new host occurs when oocysts are ingested or inhaled.
Sporozoites excyst from the oocyst (a), and invaginate
microvilli (b) . The sporozoite then differentiates into a
trophozoite (c), which undergoes schizogony (d).
Each
schizonts nucleus incorporates into a merozoite (e). These
merozoites can develop into a Type I (d & e) or Type II
schizont (f) . Merozoites from Type II schizonts initiate
gametogony.
These merozoites differentiate into either
microgamonts (g), or macrogamonts (h). The microgamete
fertilizes the macrogamont, which results in a zygote (i)
About 80% of the zygotes mature into thick - walled oocysts
and leave the hosts body (k) . The remaining zygotes mature
into thin-walled oocysts (1) and serve as a source of autoinfection. Drawing by Kip Carter , University of Georgia.
Reprinted with permission from CRC Press Inc., Boca Raton,
Florida.
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inhaled .

Modes of transmission include aspiration of

gastric contents , aspiration associated with esophageal or
or opharyngeal infection, fecal-oral spread with aspiration ,
and hematogenous spread (49, 132) .

Electron microscopy

indicates that the oocyst wall is composed of two layers;
an outer , irregular 10-nm wall separated fr om a thicker
inner wall .

The inner layer of the oocyst contains a

suture which dissolves during excystation (41, 111).
Banana-shaped sporozoites excyst from the oocyst and
invaginate microvilli.

Subsequently, the host cell mem-

brane evaginates and thin extensions of the microvillus
membranes surround the parasite and form an intracellular
but extracytoplasmic parasitiphorous vacuole which is
located at the luminal surface of the hos t cell (89, 107,
111).

A vacuo lar membrane separates the sporozoite cyto-

plasm from the host cell cytoplasm and appears to be the
precursor of the feeder organelle which may serve in the
exchange of material between the host cell and the parasite
(89 , 111) .

Spor ozoites reabsorb cytoplasmic organelles and

then differentiate into a spherical trophozoite with a
prominent nucleus.

The nucleus of the matured trophozoite

undergoes two to three asexual multiplica ti ons referred to
as merogony o r schizogony .

Two morphologic types of

schizonts have been observed.

As the type I meront

matures, each nucleus becomes incorporated into a merozoite
(4 1 ) .

Set free from the ruptured schizont , the merozoite
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becomes a motile , feeding trophozoite that can invade
another host cell where it can develop into another type I

or type II schizont (12).

Mature type I and type II

meronts contain six to eight and four merozoites, respectively (41, 66).

It is believed that merozoites from type

II schizonts initiate sexual multiplication (gametogony)
when they leave the schizont and parasitize new host cells.
These merozoites differentiate into either microgamonts or
macrogamonts, the male and female stages, respectively .
Early in . development, microgamonts become multinucleate
and, upon maturation, each nucleus becomes a microgamete
(41).

The microgamete fertilizes the macrogamont, result-

ing in a zygote.

The zygote secretes a protective protein

and lipid shell, thereby transforming into an oocyst (79),
which sporulates in situ.

About 80% of the zygotes mature

into thick-walled oocysts and leave the host' s body.
Oocysts in the gastrointestinal tract are excreted with the
feces and those in the respiratory tract are carried out
with respiratory or nasal secretions.

The thick-walled

oocysts that are released into the environment serve as the
infective stage for new hosts . Over 108 oocysts can be
excreted daily in human feces, and infective calves can
excrete up to 101 0 oocysts each day for up to 14 days (17).
The remaining zygotes (-20%) mature into thin-walled
oocysts and serve as a source of autoinfection in that they
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release their sporozoites, which then repeat cycles of
schizogony, gametogony, and sporogony .
It is not known how cryptosporidia cause clinical
disease.

Based on histological findings of villous atro-

phy, crypt hyperplasia, intimate associat i on of the parasite with absorptive cells, and inflammatory cell infiltration of the intestinal lamina propria, a number of mecha nisms of diarrhea could be postulated.

These include

impaired digestion and absorption as a consequence of
decreased villous surface area, the presence of immature,
cryptlike cells on the villi, or injury to absorptive cells
by the organism or products of the inflammatory response.
Additionally, it is possible the t oxic material produced by
the parasite could result in secretory diarrhea (6).
The broad host range, together with the high output of
oocysts, ensures a high level o f contamination of the
environment, and favors waterborne transmission.

Infected

humans, domestic animals, and wildlife may all contribute
to the pool of oocysts in a watershed through wastewater
disc harges (127).
C . parvum.

There is a lack of host specificity for

Isola tes from humans are infectious for a

variety of mammals, and isolates fr om one mammalian species
are infectious f or others (41).

Opportunities for zoonotic

transmission exist when persons are closely associated with
infected livestock (24, 118) and companion animals (42).
Additional sources of contamination include urban and
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agricultural slurry, septic tank leakage, recreati ona l
bathing, agricultural runoff, and eros i on o f so ils exposed
to infected feces (142 ) .

Waterborne outbreaks have demon-

strated that c . parvum oocysts can pass through filtration
systems currently in use and are insensitive to the standard c hl or ination regime used in the water industry (126).
The fact that surface and groundwater may be contaminated
by cryptosporidial oocysts and the lack o f effective
treatment str ess the importance of techniques to remove C.
parvum from drinking water.

c.

parvum oocysts are resistant to many disinfectants.

The survival o f c. parvum oocysts after 18 hours incubation
i n seve ral disinfectants was examined .

Only formol saline

and ammonia were effective in destroying the viability of
the oocysts (21).

Both o zone and chlorine di oxide consti-

tute a means of removing most C. parvum oocysts from
drinking water, although some oocysts may remain viable
(105 ) .

Since oocysts are resistant to many disinfectants,

prevention o f waterborne spread of cryptosporidiosis relies
on wastewater tre atment and improved filt ra tion methods.
The efficiency of oocyst removal in sewage treatment
facilities using activated sludge approaches 79 to 84% when
one compares the number o f organisms in raw versus treated
sewage (86, 142).

Chapman and Rush (1990) show that when

purified oocysts are applied to the top o f a sand filter,
oocysts do not easily pass through the filter when eluted
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with distilled water at a filtration rate of 15 m3 f m2 / hour
( 26 ) .

Treatment plants using sand filtration along with

activated sludge have significantly lower levels of oocysts
in their finish ed effluents than those us ing activated
sludge treatment alone (86).

These studies establish that

water treatment processes are capable of removing a percentage of oocysts .

However, it is important to realize

that the proportion of oocysts that penetrate the system is
dependent not only on the design and operation of the
treatment process, but also upon the number of oocysts
challenging the filters and water treatment system (126) .
Lastly, alteri ng the temperature of the contaminated water
may kill the oocysts .

Oocysts are unable to survive

freezing (126) or temperatures above 45°C (25) .

However,

the fiscal and practical implications of altering water
temperature are considerable .
Treatment

Attempts to treat cryptosporidiosis have met with
limited succes s.

At the time o f this writing, no consis-

tently effect ive parasiticidal agent or preventive vaccine
is available (5 1 ) .

Treatment remains limited to o ral or

intravenous hydra tion and hyperalimentation (administration
of greater than optimal amount o f nutrients ) (33).
Few chemotherapeutics have shown any efficacy.

some

success has been reported for arprinocid (117), spiramycin
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(100), oct r eot ide (87), paromomycin (7, 36, 52, 56),
eflornithine (121 ) , and halofuginone lactate (101).

The

effectiveness o f halofuginone remains questionable because
Tzipori et al . (1982) s how that hal o fuginone neither
prevents nor modifi es the course o f infection in neonatal
mice (135) .

Two synthetic lyti c peptides (Hectate 1 and

Shiva 10) exhibit significant activity against C. parvum in
an in vitro as say with unproven activity in vivo (8) .
Gree nberg et al.

(19 89) describe a pat ient with severe

secretory dia rrhea and malabsorption who had clinical,
microbiologic, and histologic resolution of cryptosporidiosis after the rapy with azidothymidine.

This beneficial

effect is believed to be secondary to improved cellmediated immune functions mediated by suppression of human
immunodef i c iency virus by azidothymidine (53).
Othe r treatments, such as hyperimmune bovine colostrum
(HBC) and anti -c ryptosporidial monoclonal antibodies
(Ma bs), show varying degrees of succes s .

Hyperimmune

bovine colos tral immunogl obul ins have been successfu l in
treating an AIDS patient (103 , 141) and neonatal BALB/c
mice with severe cryptosporidiosis (44 ).

The efficacy of

HBC as a immunotherapeutic agent may be explained by the
fact that each immunoglobul in isoty pe in colostral whey
recognizes meronts, mero zo ites, microgametocytes, microgametes, and macrogamonts (43 ) .

Based on these findings, it

seems that antigens in all parasitic stages provide targets
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of opportunity for the anti-parasitic activity of HBC.
Neonatal BALB /c or nude mice treated with anti-cryptosporidial murine Mabs had lower parasite loads than did
control mice (9 , 14).

Similarly, suckling BALB /c mice are

protected when sporozoites or merozoites are incubated with
Mabs or HBC before gastric inoculation (16, 108, 120).

In

contrast, dams that recovered from enteric
cryptosporidiosis did not protect their infants from
experimental cryptosporidiosis (9, 62, 97, 98).
Immunomodulation therapies appear to hold some promise
f or treating patients with cryptosporidial infections.
Rasmussen et al . demonstrate that dehydro epiandrosterone
(an immunomodulator) treatment has significant anticryptosporidial activity in experimentally infected immunosuppressed rats (112, 116) and Syrian golden hamsters
(113) .

A treatment trial with oral bovine transfer fact or

results in clinical and parasitologic cure in one o f eight
patients with cryptosporidiosis and clinical improvement in
four others (85).

Studies with interferon gamma show

promise in treati ng cryptosporidial infec ti ons (61 , 91 ,
138) .

Adopt i ve transfer of murine lymphocytes to nude

(136) and mice with severe combined immunodeficiency (SCID)
mice with chronic cryptosporidiosis causes functional
immunologic reconstitution, followed by complete eradication of cryptosporidial infection (94).

Severe combined

immunodef i cient mice injected with unprimed BALB / c spleen
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cells prior to inoculati on with C. parvum oocysts are
resistant to infecti on (91).

Conversely, neither spleen

nor mesenteric lymph node cells, nor cells or supernatant
fractions harvested from in vitro cultures, transfer
protection from resistant adult donors to susceptibl e
infant recipients (60).
Immunobiology of

C.

parvum

Most investigators believe that humoral and cellmediated immun ities are essential in removing C. parvum
from the infected host.

The role of antibodies in the

natural resolu tion of cryptosporidial infections is supported by the observation that many o f the early case
reports of human cryptosporidiosis were from patients with
immunoglobulin deficiencies (79, 125, 144).
Although the nature of acquired immunity to c . parvum
is not clear, it does result in the appearance of serum
antibodies that are specific t o C. parvum.

An immunoflu-

orescent antibody assay using tissues fr om experimentally
infected animals (28, 35, 134) or oocys ts as antigen (23,
70) demonstrates that recovery from intes tinal cryptosporidiosis is usually accompanied by a marked parasitespecific seroconversion.

The first description of antibod-

ies to Cryptosporidium sp. was reported by Tzipori in 1981
in 10 animal species, including humans.

Antibody was

detected by fluorescent antibody techniques performed on
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cryostat sections of gut tissue from an experimentally
infec ted lamb.

Antibody is present in a high proportion o f

serum samples tested (134 ) .

Campbell and Current (19 83 )

show that five of five immunocompetent persons who were
tested betwee n 360 and 400 days after recovery from a
single intestinal infection with Crypcosporidium had
detectable serum antibodies that were specific for the
parasite and which recognized all life cycle stages (22) .
Neither of these studies using histochemical methods
defined precise l y the nature of the immune response in
terms of immunoglobulin isotypes.

An immunofluorescent

study using oocysts as antigen shows that Crypcosporidiumspecific IgG, IgM, IgA, and IgE are present in the sera of
persons who recover from intestinal cryptosporidi osis (23).
Procedures using sonicated oocysts as antigen have
demonstrated that there are Crypcosporidium- specific IgG
and IgM antibodies in the sera of persons who have recovered from intestinal cryptosporidiosis (80, 137, 139, 140 ) .
Ungar et al.

(1986 ) demonstrate the presence of both

classes of Cryptosporidium-specific antibodies in AIDS
patients with prolonged cryptosporidiosi s (139, 140 ).
Moreover, specific anti-Cryptosporidium antibodies are
detected by this method in the sera of c attle (84, 99, 106,
146), rats (47), and mice (128 ) that are infected with
Crypcosporidium.
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Coproantibodies have been detected in humans and
animals after natural or experimental cryptosporidial
infections.

An enzyme-linked immunosorbent assay (ELISA)

was used to measure the C. parvum-specific IgA, IgG, and
IgM levels in stool and duodenal fluid of Filipino children
(80).

Antibody levels were measured on admission to the

hospital, 1 week later, and at 6-week follow-up examinations.

The duodenal fluid samples show higher levels of

IgA at the 6-week collection.

Stool samples have signifi-

cantly higher levels o f IgM at all three collections and
for IgG at the acute collection.

Immunoglobulin A is found

in detectable levels, though there was no difference when
compared with the controls (80).

Fecal anti-C. parvum

immunoglobulins were monitored by an ELISA after infection
of calves wit h c. parvum.

Experimental infection is

followed by a rise in local anti-C . parvum IgM levels from
day 5 PI.

Immunoglobulin M peaks at day 14 PI and then

disappears quickly.

Anti-C. parvum IgA levels increase

between days 7 and 14 PI and then slowly decrease.

Fecal

anti-C. parvum I gG levels increase slightly during oocyst
output, and IgG disappears 3 weeks PI (106).

Hill et al.

(1990) demonstrate that C. parvum-specific IgA is the o nly
isotype detected by immunofluorescent assay in fecal
extracts from infected lambs.

Specific IgA reach a mean

peak titre in these lambs on day 16 and then decline (70).
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Immunoblot analysis o f sera and intestinal secretions
of BALB / c mice orally infected with oocysts reveals that:
1) the intestinal antibody response to the parasite is
characterized by a strong recognition of antigens by IgA
and a similar but less important pattern of binding with
local IgG;
secretions;

2) no specific IgM is detected in intestinal
3) specific IgA, IgG, and IgM are found in the

sera of infected mice; and

4) the antibody response

appears in serum and intestinal secretions between day 8
and day 15 PI (119).
Although marked humoral immune responses occur, it is
unlikely that antibodies alone play a major role in acquired immunity because the membrane of host cell origin
that separates c. parvum sessile stages from the intestinal
lumen may prevent antibodies from binding to the nonmotile
parasitic stages .

It is likely that a protective response

against c . parvum involves T lymphocyte activation and
induction of specific antibody responses (34) .

Responses

mediated by B or T lymphocytes . or both, appear to play a
role in eradicating C. parvum from the intestinal muc osa .
since animals with SCID develop a severe and persistent
infection (15 , 57, 78, 91, 94, 95).

severe combined

immunodeficient animals, in addition to possessing nonfunctional B and T lymphocytes, have normal natural killer (NK)
cell counts.

The fact that chronic infections develop in

SCID mice suggests that either NK cells play a minor role
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in host responses to C. parvum or are dependent on T
lymphocytes or T lymphocyte products (e . g., cytokines) for
part of their function (9 5 ) .
The importance of T lymphocytes in the clearance of C.
parvum from the mammalian intestine is supported by several
studies.

B cell deficient

(anti- ~

treated) neonatal mice

do not differ from untreated controls in the onset , peak,
or duration of cryptosporidiosis (128) .

Parasite exposure

of nude m·ice (63, 95, 136, 138 ) and rats (47) with greatly
reduced

~

l ymphocyte function results in chronic symptomat-

ic cryptosporidios is.

In contrast, control animals (eu-

thymic) have self-resolving infections with no detectable
signs o f disease.

An

in vitro cell-mediated immune re-

sponse against C. parvum is demonstrated in the lymphocyte
blastogenesis assay.

Peripheral blood lymphocytes from

calves (146) and murine spleens (145 ) exhibit a significant
antigen-specific blastogenic response.
Considerable effort has been spent in determining
which subset of T lymphocytes is responsible for clearance
of C. parvum from the infected mucosa and for rendering the
host resistant to reinfecti on.

Flanigan et al.

(1992 ) show

that self-limited cryptosporidiosis is associated with a
higher CD4+ count (helper T cells), CD8+ count (cytotoxic T
cells), and CD4+ t o CD8+ cell ratio, although only the CD4+
count is an independent predictor of self-limited disease
(45).

Chronic C. parvum infection can be produced in
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infected mice that are treated with anti - CD4 Mab with or
without anti-CD8 Mab treatment (136 , 138) .

In contrast,

infected mice that receive anti-CD8 Mab alone cease shedding detectabl e oocysts.

In a similar study MHC class II

deficient mice !lacking functional CD4+ cells) dosed with
oocysts remain infected 8 weeks postexposure Ill .

In

contrast, MHC class I deficient mice (lac king functional
CD8+ lymphocytes) clear C. parvum infections similar to
age-matched controls.

Unlike those studies performed in T

lymphocyte deficient mice, others have shown the effect of
C. parvum on lymphocyte subpopulations .

Experimenta l

cryptosporidial infections in adult female C57BL/6 mice
show that T cells (thymi c and splenic) are significantly
higher than in the uninfected co ntrols.

Moreove r, CD4 +

lymphocytes in the spleen are increased in those mice with
cryptosporidios is (37).
Another study used neonatal mice to characterize the
leucocyte subgroups present in PP from the ileum and
jejunum o f c. parvum-infected mice .

This study shows that

ileal and jejuna l PP are functionally different in response
to C. parvum.

Moreo ver , Boher et al.

(1994 ) suggest an

involvement of jejunal PP in T lymphocyte dependent immuni ty against the parasite , whereas ileal patches may be
associated with B lymphocyte expansion and maturation (18).
The systemic and localized immune responses have been
determined in similar studies o f intestinal and extrain-

20

testinal parasites, such as Eimeria spp . {74) Ascaris suum
{88), Giardia spp. {65, 66) , Trichinella spiralis {32),

Strongyloides stercoralis {48), Taenia hydatigena {96), and
the larval form of Dermatobia hominis {54).

Although there

are substantial differences in the biology of Giardia spp.
and

c . parvvm , the immunological responses to these para-

sites are astoundingly similar {Table 1 ).

As in the case

of cryptosporidial infections, immunologic clearance of
giardiasis depends on lymphocytes bearing CD4+ receptors.
One difference t hat should be noted, however, is that the
susceptibility of immunocompetent rodents to C. parvum is
age related.

Neverthe less, studies investigating the

dynamics of the immune response to these parasites will be
useful in developing parasiticidal age nts and immunomodulation therapies.
Very little is known about the immunological response
to cryptosporidiosis that does not involve the recognition
of antigen by lymphocytes and the mounting of specif i c
immune responses {e . g ., nonspecific immunity, anatomical
barriers, etc. ).

Experimental cryptosporidial infections

in fe tal lambs shows that hypercel lular ity of the
intestinal lamina propria occurs and consists of a mixed
infiltration o f neutrophils, M0, and eosinophils.
Moreover, there appears to be an increase in phagocytic
activity with time {77 ) .

The role that granulocytes play

t hat c . parvum infections in mice with a deficit in ery

21

TABLE 1. List o f cell phenotypes invo lved in
Giarida spp. and Cryptosporidium infections
Cell Type

IgG
IgM
IgA
IgE

CD4+
CD8+
producing
producing
producing
producing
NK

Giardia spp.
+ ( 67)
- ( 67 )
+(13, 75)
+ (1 3, 75 )
+ (13, 75)

Cryptosporidium

Unknown?

+ ( 1, 37 )
- ( 1, 138 )
+ ( 80, 137)
+ (80, 137 )
+ (70 , 80)
+(23)

- (68)

- ( 95 )

+plays a role in the clearance of parasitic infection (Ref.)
-plays no role in the clearance of parasitic infection ( Ref. )
NK = natural killer

throcytes, granulocytes, and mast cells are similar to in
the elimination of c. parvum is uncertain because Harp and
Moon (1991) show infections in normal mice (58 ).

The role

of M0 is more complex than that of granulocytes.

In

addition to having important pi1agocytic functions, M0 can
participate in the initiation of a specific immune response
by processing the antigen and presenting it to l ymphocytes
(30, 82).

Conceptually, M0 should exert an active defense

against C. parvum , however the parasite appears to be
resistant to lysosomal di gestion.

It is this resistance

that permits C. parvum to multiply in the cytoplasm of M0;
therefore , parasites within M0 may gain access to other
organs and tissues (90).

Nevertheless, parasites within M0

are particularly vulnerable to the effects of M0 products
if their defenses break down (31).

Additional evidence
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that supports the invol vement of nonspecific mechanisms of
resistance in cryptosporidiosis is supported by studies
done with germ- free and flora - bearing mice (57 , 60).
Intestinal

immunity

The mucosal epithelium overlying the PP appears to be
modified for immune function, specifically the uptake and
transport of luminal antigens across the epithelium.

In

the small-intestinal PP , specialized epithelial cells,
designated "M cells" (mic rofold cells), have been reported
to be capable of transporting particles ranging in size
from proteins to intact cryptosporidia (89 ) from the lumen
to underlying lymphoid tissue.

This path o f entry presum-

ably permits antigenic sampling by the intestinal immune
system.

Mechanisms other than invasion of the mucosa that

might provoke an immune response includes apoptosis, which
can take place in enterocytes.

This "programmed" cell

death may result in antigen being presented t o the immune
system by phagocytes that have eliminated these membranebound particles (23) .
The majority of T and B lymphocytes continuously
recirculate between the secondary organs (i . e., lymph nodes
and PP) and the bloodstream .

This continuous recirculation

not only ensures that the appropriate lymphocytes will come
into contact with antigen, but also ensures that appropriate lymphocytes will encounter each other .

Lymphocyte
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recirculation depends on specific interactions between the
lymphocyte glycoproteins on the cell surface and the
surface of specialized endothelial cells lining small veins
(ca lled postcapillary venulesl in the secondary lymphoid
organs.

Some lymphocytes express specific glycoproteins

that attracts them to the PP; these cells constitute a gutspecific subsystem of lymphocytes specialized for responding to antigens that enter the body from the intestine (2) .
After the lymphocytes percolate through the PP, they
accumulate in postcapillary venules that leave the PP and
connect with other lymphatic venules.

Passing into in-

creasingly larger vessels, the lymphocytes eventually enter
the systemic compartment (2).

Within the systemic compart-

ment (including the spleen), the lymphocytes differentiate
(93, 131 ) and eventually enter the bloodstream.

Lympho-

cytes then leave the blood stream and migrate to the lamina
propria of the intestinal villi and other mucosal sites by
squeezing between specialized endothelial cells (2) .
Hypercellularity of the intestinal lamina propria is
an essential component of intestinal immun i ty.

Many

lymphocytes and immunoglobulins make their way through the
lining epithelium to enter the intestinal lumen (55).
These antibodies presumably eliminate the parasite by
mediating biological processes including motility, attachment to the host cell, modification of the host membrane,
and entry into the host cell (11 1).

Moreover, antibodies
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may result in opsonization of the parasite for killing by
complement or by the mechanism of antibody-dependent
c ellul a r cyt o toxicity (38 ) .

Lastly, secretory antibodies

(IgA) can be transported across epithelial cells of the
intestine from the basal to the apical surface of these
cells by transcytosis (2).

Consequently, it is reasonable

to speculate that c. parvum-specific IgA might reach the
basal membrane of attached cryptosporidia directly via the
epithelial cell cytoplasm.
Immunosuppressive

agents

Dexamethasone is a potent synthetic glucocorticoid
that has str iking pharmacologic effects on lymphoid tissues
and cells.

These effects form part of the basis for the

widespread use of corticosteroids in the treatment of a
variety of diseases involving immunologic, inflammatory, or
neoplastic processes.

The efficacy o f DEX in the treatment

of various inflammatory and immunological processes can be
accounted for by a combination of mechanisms such as
inhibitory action on the production of important lymphokines and monokines.

Additional mechanisms include : 1)

effective change in the traffic of various leucocyte
populations; and 2) ability to lyse lymphocytes through
induction or enhancement o f the action of a specific DNAase
(4), resulting in digestion of cellular DNA.

Animals have

been divided into glucocorticoid-sensitive and gluco-
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corticoid-resistant groups.

Glucocorticoid-resistant

species include most domestic animals as well as man,
ferret, guinea pig, and monkey, whereas the rat, mouse,
hamster, and rabbit are considered glucocorticoid-sensitive.

The differentiation is usually based on the

relativ~

ease of producing lymphoid depletion af ter a given regimen
of systemi c glucocorticoids (29).

The differences in

susceptibility to glucocorticoids are often overlooked .
However, they are of crucial importance in the interpretation of data .

Therefore, the emphasis of this review

concerns the effects of DEX in murine models.

In sensitive

animals, glucocorticoids profoundly affect lymphoid tissues.

The animals exhibit lymphopenia (20) and shrinkage

of the thymus, spleen, and lymph nodes.
Inhibition of circulating antibody production by DEX
has repeatedly been shown in glucocorticoid-sensitive
animals.

For example, rats treated with DEX have lower IgG

levels in serum (115, 147), saliva, and vaginal secretions
(147).

Rodents treated with DEX have elevated IgA levels

in serum , while IgA levels decrease in saliva, vaginal
sec retions (147), and bile (3) .

Moreove r, C57BL/6N mice

that are immunosuppressed with DEX have fewer total B
lymphocytes in the spleen (115).
In glucocorticosteroid-sensitive species, there has
been relatively little study of classic manifestations of
cell-mediated immunity.

Immunosupp ression of murine CD4 +
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cells (115, 124) and total T lymphocytes (115 ) is brought
about by DEX .

Helper T lymphocytes are believed to be more

responsive to glucocorticoid-media ted irnmunoregulatory
effects than CDS + cells because they are more migratory as
immature cells (27) .
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MATERIALS
An i mal

housing

and

AND

METHODS

husbandry

Female C57BL / 6N strain mi c e weighing 14 t o 16 grams
(approximately 5 to 6 weeks old) were purchased from
Simo nson Laboratories (Gilroy, CA) and maintained in the
Laborat o ry Animal Researc h Center at Utah State University.
Mice were housed in trans pa rent plastic cages with s tain less steel wire lids at approximately 22°C and a 12-hour
light-dark cycle.

These a nimal cages were kept in high-

efficiency particulate ai r- filtered laminar flow units.
Five mice (within the same treatment group) were housed per
cage, o n corncob bedding with food and water provided ad
libitum.

The mice were randomly placed into one of the

f o llowing groups (see Fig. 2 f o r a graphic illustratio n o f
the gr oups described bel ow) :
Group 1.

Mice were immunosuppressed with daily DEX

intraperitoneal injections for the duration of the experi ment.
Group 2.

Mice were immunosuppressed with DEX by daily

intraperitoneal injections and oocysts of c . parvum were
intragastrically administered (106 oocysts / mouse) 3 days
after immunosuppression began.

All mice within this gro up

continued to receive DEX intraperito neally after oocyst
inoculation and throughout the duration of the experiment.

(n) = mice per group

1 ) DEX Only (41)
2) DEX /C . parvum (34)
3)

C. parvum Only (36)

0 , 3,6 , 9,18

days posti:1fectior

4) Normal (44)

s leen
pp

Figure 2. Experimental design for investigating the phenotypic pro files o f cells in
mice treated with dexamethasone (DEX) and infected with Cryptosporidium parvum.
Monoclonal antibodies directed against CD4+ and CD8+ T cell s (helper and cytotoxic ,
respectively), and B cells (e xpress ing IgG, IgM, and IgA recept ors) , and macrophages
(M0) were used to quantify these leucocytes within the splee ns and Peyer ' s pat ches (PP)

"'

(X)
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Since the prepatent period of c. parvum is 3 days, no mice
were killed on day 0.
Group 3.

Mice received intragastrically 106 c. parvum

oocysts per mouse.

No mice were killed on day 0, because

it takes 3 days for a patent cryptosporidial infection to
develop.
Group 4 .

This group of mice served as the nonimmuno-

suppressed / noninfected (normal) controls.
Spleen tissues were used t o represent the systemic
immune

r~sponse

and the PP from the small intestine were

used to determine the localized immune response .

In order

to determine the best methodology for this study, avidin
biotin complex staining, the ELISA-spot assay, flow cytometric, and immunofluorescence techniques were employed.
Of the f our methodologies, flow cytometric analysis proved
t o be the most suitable.

Flow cytometry and Mabs directed

against lymphocytes bearing CD4+ , CDS+, IgG, IgM, I gA, and
M0 receptors were used to characterize the kinetics of the
cell populations in mice infected with c . parvum.
Immunosuppression

of

mice

The immunosuppressed adult mouse model established by
Rasmussen and Healey (1 14 ) for chronic cryptosporidiosis
was used in this experiment.

Limitations within this

experiment necessitated slight modifications of their
originally proposed protocol.

Briefly , DEX (Sigma Chemical
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Co., St. Louis, MO } was diluted from a stock solution (6 . 25
mg / ml in absolute ethanol ) to a working solution (0.625
mg / ml in sterile water ) and administered in a daily regimen
of 125

~g

per mouse.

All mice within groups 1 and 2

received DEX by intraperitoneal injection through a 26 1 / 2
gauge syringe needle throughout t he duration of the experiment .

Mice in group 2 received DEX 3 days before infection

with C. parvum.

Nonimmunosuppressed mice received similar

injections with 0.2 ml of sterile water .
Oocyst

production

and

purification

C. parvum oocysts originally isolated from Holstein
calves and obtained from Dr . Harley Moon (NADC, Ames, IA )
were used to infect 1- to 2-day -old Holstein calves.

At

the peak o f oocyst shedding , feces were collected daily,
mixed with an equal volume of 5% potassium dichromate
{K2Cr207l, and stored at 4°C .

Feces were strained sequen-

tially through stainless steel screens with a final mesh
size of 230 (63

~m

porosity}.

Oocysts were purified from

feces using discontinuous sucrose gradient centrifugation
techniques (10).

In brief, the discontinuous sucrose

gradients used in the oocyst purification process were
prepared from Sheather's s olution (320 ml H20 , 500 g
sucrose ) diluted with 0 . 025M PBS and supplemented with 1%
Tween 80.

Eighty milliliters of 1:4 solution (specific

gravity 1.064 ) were layered over 80 ml of the 1 : 2 solution
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(specific gravity 1.103) in 250-ml polycarbonate centrifuge
bottles.

A 40 - ml aliquo t of the strained feces in potassi-

um dichromate was layered over the 1:4 solution.

Tubes

were centrifuged at 1500 X g for 25 min and the oocysts
were recovered fr om the interface of the sucrose layers and
washed with 0.85% saline at 1500 X g (twice for 10 min ) .
The pellets were resuspended to 40 ml with 2.5% potassium
dichromate, dispensed in 5-ml aliquots over new gradient
tubes (10 ml 1:2 Sheather's layered over 10 ml o f 1:4
solution), and centrifuged as before.

Pellets from the

oocyst-conta ining layers of the second centrifugation were
resuspended in potassium dichromate and stored at 4°C.
Oocyst

preparation

i noculation

of

and

mice

Experimental murine cryptosporidial infections of
groups 2 and 3 were established by using oocysts (less
4 months o ld ).

tha~

oocyst inoculations were prepared by

washing oocysts three times with sterili zed RPMI 1640 cell
. culture medium (Sigma Chemical Co . ) to remove the potassium
dichromate.

washed oocysts were then enume rated using a

hemocytometer observed under bright field micr oscopy and
diluted to 106 oocysts per 100 ~ 1 of RPMI 1640 base medium.
Mice were inoculated intragastrically with 106 purified
oocysts through a 22-gauge straight feeding needle.
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Fecal
and

collection
examination

Fecal pellets were collected from each mouse on every
third day of the experiment to monitor oocyst shedding.
Mice were removed from their cages and held briefly in a
laminar flow hood to allow for collection of feces.

Fecal
~1

samples were stored in microfuge tubes at 4°C in 300
2.5% potassium dichromate solution until analyzed.

of

Fecal

samples were prepared on microscope slides and assayed for
the presence of oocysts using a fluorescent - labeled oocystspecific Mab-based indirect immunofluorescent assay (11) .
Briefly, fecal samples were broken apart with a disposable
applicator stick and then well vortexed.

Four bacterial

loops of feces were smeared on the slide to cover approximately the area equivalent to a quarter dollar.
were air-dried and fixed by heat.

Slides

Fifty microliters of

undiluted hybridoma supernatant containing anti-oocyst Mab
9D10 (i sotype I gM) produced in this laboratory were applied
over the fecal smears .

Fecal smears were then incubated

for 30 min at 41°C and 100% humidity.

Unbound antibody was

removed by washing slides in three changes of PBS for 3 min
each.

Care was taken to wipe off excess PBS from the

slides before applying the second antibody.

Fluorescein

isothiocyanate (FITC) labeled goat anti-mouse IgM (Hyclone
Laboratories Inc., Logan, UT) diluted 1 : 60 in PBS was then
applied to the fecal smear (90

~ 1)

and incubated as before
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for 30 min.

Specimens were washed in PBS as before to

remove unbound anti body.

Slides were mounted with 1:1

glycerol/PBS and covered with glass coverslips (0.17-0 . 25
mm thick).

Prepared slides were stored at -20°C until

examined with epifluores cence microscopy .

Slides were

examined using an ultraviolet light microscope (Carl zeiss,
Oberkochen, Germany) and the number o f oocysts observed in
a single pass (40x objective) through the center of the
fecal smear was counted.
Histological
and

collection

examination
Terminal ilea were harvested and fi x ed in 10 ml of 10%

buffered formalin (pH 7 .5 ), embedded in paraffin, sectioned
(4 ~m ), and stained with hematoxylin and eosin .

Stained

sections were examined for c. parvum colonization by using
bright field microscopy in a blinded fashion .

Parasites

were quanti fied by counting the intestinal epithelial cells
and the parasites fr om the apex of a villi to the apex of
the adjacent villi.
Avidin
(ABC)

biotin

Five random villi were counted.

complex

staining
Immunoperoxidase staining was done on paraffin-

embedded tissue sections according to the method of Loose
et al.

(83) .

Briefly, the spleen, terminal ileum, and

semitendinosu s muscle were harvested and fixed in B-5
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fixative (described in the f o llowing section) for either 3,
5, 7, or 7.5 hours.

Tissues were then processed, embedded

in paraffin, and sectioned in a routine manner .
were heated to 70°C for 5 min.

The slides were then

treated with the following reagents :
2 ) cold 95% ethanol for 5 min ;
min;

Sections

1) xylene for 5 min;

3) cold PBS wash for 10

4) 0 . 3% hydrogen peroxidase-methanol mixture for 30

min to quench endogenous peroxidase activity;
for 10 min;

5) PBS wash

6) normal goat blocking serum for 30 min;

7)

biotinylated anti-mouse Ig (Hyclone Laboratories Inc.), IgA
(Sigma Chemical Co . ), or CD4 (PharMi ngen, San Diego, CAl
Mabs for 30 min. Negative controls included biotinylated
goat anti-swine IgG (Vector Laboratories . , Burlingame, CAl
and the omission of i) primary antibody ii) streptavidin
horseradish peroxidase, and iii) diaminobenzidine tetrahydrochloride (DAB);

8 ) three PBS washes for 5 min each;

9)

streptavidin horseradish peroxidase complex reagent (Hyclone Laboratories Inc.) for 45 min;
for 5 min each;
saline with 12

10) three PBS washes

11) DAB 132 mg in 15 ml of Tris buffered
~1

of 30% hydrogen peroxide) for a 5 min

i ncubati on; and 12) a tap water rinse to stop the reaction.
To eliminate background staining , modifications of
previously described procedures were used and adapted to
this methodology (5 , 19, 39, 64, 71-73, 81, 122, 143).
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Immunofluorescence

techniques

Tissues were harvested and prepared immediately after
mice were killed.

In order to determine the optimal

fixacion condit ions of the cissues, trials using the
following fixacives, at varying time lengths, were attempted ( 4 0 , 14 9 ) :
1) B-5 fixative: 90 ml aqua dest, 6 g mercuric chloride, 2 . 074 g sodium acetate and 10 ml of 37%
formaldehyde solucion, pH 5 . 7;
2) 10% buffered formalin: 10 ml of 37% formaldehyde
solution and 90 ml of PBS, pH 7 .5;
3) Bouin's solution (Sigma Chemical Co.); and
4) Histochoice tissue preservative (Ameresco, Solon,
OH).

Specimens were processed, embedded in paraffin, and
sectioned in a routine manner.
(4

~ m)

After embedding, seccions

were cut and prepared for deparaffinization and

direcc immunofluorescent staining according to the method
of Dorsett and I oachim (40), with slight modifications.
Slides were heated for 30 min at 80°C.

Deparaffinization

was accomplished by a 5-min wash in xylene and sequenti al
passage through two changes each of absolute echanol, 95%
ethanol, 80% ethanol, and PBS (0.025M PBS, pH 7.3).

Rehy-

drated sections were washed for 2 hours wi th constant
agitation in PBS to remove the remaining fixati ve.

Sec-

tions for direct immunofluorescence wer e chen overlayed
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with FITC-labeled antiserum diluted appropriately in PBS
and incubated in a humid chamber at 41°C f o r 1 hour.
Controls consisted of sections in which a Mab of irrelevant
specificity was subst ituted for the FITC-labeled antibody.
Unbound antibody was removed by washing in three changes of
PBS for 10 min with constant agitation.

Slides were

counterstained with 3% methyl green (dilu ted in methanol)
for 1 to 2 min, followed by a brief rinse in distilled
water.

Cove rslips were added with 1:1 glycerol / PBS.

Tissue sections were examined microscopically in a blinded
fashion.
Because the antibodies may have been affected by
buffers, incubation times, and relative conditions , this
protocol was altered.

The following buffers were tried for

washing and to dilute the antibodies: 0.9% saline; 50mM
Tris buffered saline; and 0.025M PBS.

All buffers were

tested with or without bovine serum albumin (BSA) .

This

was done because BSA may effect antigen recognition by
certain antibodies (130).

Slides were overlaid with

"antibodies (undiluted to 1:1000) and incubated at either
4°C or 41°C and 100% relative humidity.

Tissue sections

were incubated under these conditions for 0.5, 1.0, 1.5, or
14.0 hours.
An

indirect immunofluorescent assay was carried out as

described in the previous paragraph, with the following
modifications.

Bef ore the tissue sections were over layed
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with FITC-labeled anti s erum, rat antibodies directed
against mouse CD4+ and CD B+ lymphocytes (Gibco BRL,
Ga ither s burg, MD) were applied to the sections.

Slides

were incubated for 1 hour at 41°C and 100% relative humidity.

Slides were washed in three changes of PBS for 10 min

each .
Cryo s tat

preparation

The cryostat chuck was sto red at -20°C.

A thin layer

o f OCT-embedding compound was applied to the chuck.

A

spleen was placed on the chuck and additional OCT-embedding
compound was applied to cover the entire tissue .

The

spleen was cut on the microtome and appl ied to gelatin
coated (subbed ) slides.

Slides were allowed to air - dry and

then fixed by immersing in acet one for 5 min.

Slides were

sto red at -2 0°C (<24 hours) until stained by immunofluo res c ent techniques as previously described in the sectio n
outlining tissue preparation and imrnunocyte detection.
ELISA-spot

technique

A modification of the ELISA-spot techniques of Franci
et al.

(46 ) and Pestka et al.

(109 , 110) was attempted to

quantify splenic lymphocytes in immunocompeten t mice.

In

brief, a 96-we ll microtiter ELISA plate was uniformly
coated with gelatin solution or polY-L-lys ine.

Each well

was washed in PBS, emptied, and 0.3 ml of lymphocyte
suspension (10 5 to 106 cells / ml ) in RPMI 1640 containing
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0.5% BSA was added to u n i f o r mly cov er the bottom of the
plate.

The plates were c entrifuged for 5 min at 450 g.

Biotin conjugated g o at anti-mouse Igs,

IgA, and CD4 Mabs

(diluted appropriately in 1% BSA-PBSI were added and plates
were incubated for 60 min at 41°C.

Plates were washed four

times with PBS containing 0 . 5% Tween 20, and streptavidin
horseradish peroxidase wa s added.

Plates were covered and

incubated at room temperature f o r 30 min.
PBS washes, DAB solutio n was applied.

Incubation was

continued for 5 min o n ice a nd in the dark.
was s topped with a PBS wash.

Following three

The reaction

Plates were examined at low

power under a dissecting microscope for brownish spots
which were indicative of lymphocytes .
Cell

staining

for

flow

cytometry

Immediately after the mice were killed, spleens and
intestines were removed fr om the peritoneal cavities.

The

intestine was cut -0.5 e m below the stomach and just above
the c ecum.

Both spleen and small intestine were immedi-

ately placed in plastic petri dishes with RPMI 1640 containing 1 mM EDTA (ethylenediaminetetraacetic acid),
prevent drying.
from the tissues.

to

Fat and connective tissue were removed
The spleen was weighed and set aside

until the PP were harvested.

Peyer•s patches were removed

by grasping them with a f o rceps and excising with a
scalpel.

Spleens and PP were put into separate stomach
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bags with RPM I / EDTA solution and homogenized in a stomacher
(Tekmar Co . , Cincinnati, OH) for approximately 1 min .

The

resulting cell suspensi on was poured into 15-ml tubes .
Visible intestinal pieces and spleen capsules were removed
with disposable applicator sticks.

Cell suspensions were

centrifuged for 5 min at 300 g, followed by decantation of
the supernatant .

Nine ml o f double distilled water was

added to the spleen cell suspensi on to lyse erythrocytes.
One to 2 seco nds after hemolysis, 1 ml o f lOX PBS (80 g
NaCl, 2 g KCl, 11.5 g Na 2HP04, 2 g KH2P0 4, and 1000 ml
water) was added to prevent from lysing.

After centrifug-

ation at 300 X g for 5 min and decantation of the super natant, the cells were washed two times in RPMI solution
with 2% fetal bovine serum (FBS).

Before staining , the

cells were washed with RPMI solution without FBS.
pellet was resuspended in 0 . 5 ml o f RPMI solution .

The
The

remai ning leucocytes were counted with a Coulter Counter
(Coulte r Corp., Hialeah, FL ) and aliquoted into polypropylene sample tubes (106 cells / 100 ~ 1).

This 100 ~ 1 aliquot

was stained with a mixture of Mabs: R-phycoerythrin (R-PE)labeled anti-mouse CDS and FITC-labeled anti-mouse IgM
Mabs.

A second tube with a 100

~1

aliquot of cells was

stained unde r identical conditions with a mixture of R-PElabeled anti - mouse CD4 and FITC-labeled anti-mouse IgG
Mabs.

Similarly , a third tube with a 100

~1

aliquot of

cells was stained with R-PE-labeled anti-mouse M0 and FITC-
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labeled anti-mouse IgA.

All antibodies were diluted in

0.025 M PBS as recommended by the supplier.

Staining was

done at room temperature in the dark for 20 min.

The cells

were then fixed with 1 ml of 0.5% paraformaldehyde (Sigma
Chemical Co. I .
before.

Samples were immediately centrifuged as

Supernatant was decanted and 0.5 ml of PBS added.

Samples were kept <24 hours in the dark at 4°C until
analyzed by flow cytometry.
Ant i body

specificit i es

controls

for

flow

and

cytometry

Goat antibodies directed against mouse IgG, IgM, and
IgA were obtained from Sigma Chemical Co.

Rat antibodies

directed against mouse CD4+ and CD8 + cells were purchased
from PharMingen.

Fluorescent-labeled rat anti-mouse M0

antibody was obtained from Caltag Laboratories (San Francisco, CAl .

These antibodies were affinity purified by the

supplier and tested for specificity against the relevant
class of mouse antibodies by immunoelectrophoresis.

The

affinity-purified antibodies were conjugated to FITC or RPE by the supplier.

Negative antibody controls for testing

nonspecific binding were prepared as previously described
in the paragraph on flow cytometric cell staining.

Howev-

er, the antiserum for the B lymphocyte populations was
FITC-labeled goat IgG and R-PE-conjugated rat IgG2a Kappa
isotype for the CD4+ and CDB+ populations.

The isotype
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control used for the M0 populations was R-PE-conjugated rat
IgG2b.
Fl o w

cytometric

analyses

Dual-color fluoro chrome analysis was performed with an
EPICS-C model flow cytometer (Coulter Corp.) equipped with
an argon lase r set at 488 nm.

Cells were carried in double

distilled water as sheath fluid through a 76-micron flow
tip.

Twenty-five hundred cells were analyzed for each

sample.

Fluorescence data for FITC and R-PE were obtained

using a bit-map format gated on the forward light scatter
versus ninety-degree light scatter.

Fluorescence intensity

was standardi zed using latex beads of 10 mi crons (Coulter
Co rp. ) and by adjusting the laser power to place the loggreen histogram in channel 119 (148).
Statistical

analyses

For each of the four treatment groups, eight mice were
killed on each scheduled date, with the exception of groups
2 and 3 on day 0.

Of the eight mice from each treatment

group , the respecti ve tissues (spleens and PP) from four
mice we re pooled , resulting in two repetitions.

Spleen

cell percentages reported by the flow cytometer were
multiplied by the mean of their spleen weight to estimate
absolute numbe rs.

A square root transfo rmati on was re-

quired to stabil ize variances prior to statistical analysis.

Because data were not collected from groups 2 and 3
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on day 0, multiple analyses of variance were performed to
compare differences between animal groups on different
dates.

Least significant differences (LSD) were done co

compare different groups within a dace and differen t dates
within a group.
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RESULTS

Immunohistochemistry
Identification
embedded sections.

of

lymphocytes

in

paraffin -

Direct immunofluorescence techniques

applied to paraffin-embedded sections sta ined B lymphocytes
in the spleen and intestinal lamina propria .

Three to 7

hours of fixation in B-5 fixative resulted in poor morphol ogical preservation, although immunohistochemical reactivity with B lymphocyte receptors could be detected.

Plasma

cells stained weakly in the tissues that were fixed in
Histochoice tissue preservative.

Fixation in 10% buffered

formalin for 4 to 7 hours showed reactivity for plasma
cells, although it was relatively unsuitable for quantitating lymphocytes in the intestinal lamina propria.

Fixation

in Bouin ' s solution for 6 hours resulted in excellent
preservation of morphology and proved to be a good fixative
for lymphocytes bearing Ig receptors, which showed complete
preservation of their capacity to react with FITC-labeled
antibodies (Figs. 3 and 4).
A pilot study using direct immunofluorescence on
paraf fin -embedded tissues demonstrated that lymphocytes
bearing IgA receptors a re significantly decreased in 9week-old mice that were immunosuppressed.

Administration

of DEX for 20 days significantly reduced the numbers
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FIG . 3.
Immunofluorescent (A) and methyl green (B)
staining of the terminal ileum of a control mouse.
Note
the fluorescing B lymphocytes (express i n g I gA receptors)
present in the lamina propria (400x) .
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FIG. 4.
Immunof luorescent (A) and methyl green (B)
staining of the spleen of a control mouse.
Note the
fluorescing B lymphocytes expressing IgM recept ors (400x) .
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FIG. 5. Immunohistochemical evaluations
compar ing splenic lymphocytes in Cryptosporidium
parvum (Cpl-infected mice to dexamethasone (DEX)treated mice with chronic infections. Bar height
represent s the mean number o f lymphocytes counted
in 15 random fields (400x). Error bars indicate
standard deviations of the mean . * indicates
significance (P<0.05) when compared to DEX + Cp.

of B lymphocytes expressing IgA receptors in the spleen and
intestinal lamina propria (P<0 .05 and P<0 . 02 , respectively).

The number of IgG and IgM receptor bearing B cells in

these mice were not significantly different from those of
the nonimmunsuppressed contro ls (Figs. 5 and 6).
Direct and indirect immunofluorescent stainings were
unsuitable for immunohistochemical examination o f M0 and T
lymphocytes.

Altering the buffer conditions, incubation

times. and temperatures failed to stain M0, CD4+, or CD8 +
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FIG . 6. Immunohistochemical evaluations
comparing lymphocytes within the ileal lamina
propria of Cryptosporidium parvum (Cp)-infected
mice to dexamethas one (DEX )- treated mice with
chronic infecti o ns . Bar height represent the
mean number of lymphocytes counted in the lamina
propria of 15 villi. Error bars indicate
standard deviati ons o f the mean . * indi c ates
significance (P<0 . 02) when compared t o DEX + Cp .

ce lls within the spleen or intestinal lamina propria.
However, the plasma cells stained with each alteration.
Immunofluorescent

stain i ng

of

frozen

sections .

Immunofluo rescent techniques applied to frozen sections had
several shortcomings that limited their application to this
study.

The antiquated c ryostat microtome cut the tissue s

in varying thicknes ses that were thicker than desirable.
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Although immunohistochemical reactivity of B lymphocytes
was evident in the spleen, this technique resulted in poor
morphological preservation, insufficient resoluti on , and
nonspecific fluorescence.
Immunoperoxidase

staining.

Avidin biotin complex

staining on pa raffin -embedded tissues was unsuccessful.
Modifications of the protocol (i.e ., antibody and enzyme
dilutions, filtration o f substrate, incubation time and
temperature, blocking nonspecific binding, and blocking
endogenous peroxidase activity) failed to eliminate background staining .
ELISA-spot

technique .

Attempts to stain lympho-

cytes with the ELISA-spot technique were met with limited
success.

Some immunochemical reactivity was noticeable.

However, the modifications made to this technique resulted
in clumps of lymphocytes aggregating at the edge of the
wells.

In addition, there was considerable nonspecific

binding .
. Infection

dynamics

Oocyst
following

C.

production

and

intestinal

parvum infection.

colonization

All mice were confirmed

to be uninfected with C. parvum when the experiment began.
Both control groups (normal and immunosuppressed mice)
remained uninfected with C. parvum throughout the experiment.

All mic e in groups 2 and 3 , respectively, were
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FIG. 7 . Fecal oocyst shedding intensities
comparing C~ptosporidium parvum-infected mice
immunosuppressed with dexamethasone (group 2 )
and nonimmunosuppressed mice (group 3 ) . Data
are illustrated as mean oocysc intensity. Error
bars indicate standard deviations o f the mean.

shedding oocysts by day 3 PI.

However, after day 9 PI, all

mice in group 3 had ceased shedding and remained negative
for fecal oocysts throughout che experiment.

All mice in

group 2 continued to shed oocysts until the experiment was
terminated (Fig . 7 ) .
Similar results were observed when ileal sections were
examined for parasite colonization .
notable difference on day 3 .

However, there was a

Mice in groups 2 and 3 shed

approximacely an equal number of oocysts 3 days postinoculation, whereas histo l ogical examinacion of the terminal
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parvum comparing mice treated with dexamethasone
(group 2) and nonimmunosuppressed (gr oup 3) mice.
Data are shown as the mean parasite to epithelial
cell ratio. Error bars indicate standard
deviations of the mean.

ilea showed notably more parasite per epithelial cell in
infected immunosuppressed mice (Fig . 8) .
Effects

of

DEX

and

C . parvum

on

spleen

we i ghts .

When DEX was administered for 3 consecutive days, the mean
spleen weight o f mice in groups 1 and 2 was about 30 mg
less than the average spleen weight of non i mmunosuppressed
mice in groups 3 and 4.

After an initial decrease, spleen

weights of immunosuppressed mice remained fairly constant.
C. parvum did not significantly affect splenic weights.
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Day of Experiment
FIG. 9. Effects of Crypcosporidium parvum and
dexamethasone on spleen weights.
Data a r e presented
as the mean of spleen weights.
Error bars indicate
s tandard deviations of the mean.

Effects

of

DBX and

C.

parvum on

body we i ghts .

Mice that were not immunosuppressed gained weight steadily
as the experiment progressed.

Mice from groups 1 and 2

lost weight during the first 12 days of immunosuppression.
On day 18 (21 days after immunosuppress i o n began), the mice
in group s 1 and 2 gained weight (Fig . 10).
Flow

cytometric
Comparative

l ymphocytes

analysis
effect

within

of

trea t ment

c.

parvum on
groups.

splenic

With the excep-

tion of an isolated incident on day 3, no statistical
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FIG. 10 . Effect ofCrypcosporidium parvum and
dexamethasone on body weight. Data are expressed as
the mean weight gain. Error bars indicate standard
deviations of the mean.

difference was present when the absolute number of splenic
lymphocytes of infected and normal mice were compared.
day 3 PI,

c.

On

par vum-infected mice had s ignificantly lower

levels (P<0 .05 ) of cells bearing IgA receptors than the
normal controls.

Furthe rmore, there were no significant

differences in the absolute numbers o f splenic cells
(expressing CD4+ , CD8+ , IgG, IgM, IgA and M0 receptors)
when mice from groups 1 and 2 were compared (Table 2) .
Comparative
splenic

effect

of

C.

lymphocytes over time.

parvum

exposure

on

The absolute numbers of

M0 and T lymphocytes bearing CD4+ and CD8+ re ceptors were

TABLE 2.

Phenotypic profile s of lymphocytes• in the spleens of

Cryptosporidium parvum- infected and control mice

Cell

T:n~e

Day

grOUE 1

g:rouE 2

g:rouE 3

grouE 4

CDS+

0
3
6
9
18

2 . 11±0.10
2.23±o.osct
2 .19±0 .22d
2.10±0.09d
2.77±0.05

No§
2.50±0 . 10C
2.05 ±0.13
1.62±o.osct
2.48±0.08

ND
2.30±0.09
2.08±0 . 25
2.03±0.17
2.35±0.01

2.76±0.91
2 . 38±0.0 2
2.25±0.22
2.09±0.17
2 . 32 ±0. 26

CD4+

0
3
6
9
18

1. 4 9±0. 24abcdB
2 . 65±0.218
2. 70±0. OlAB
2. 92±0. 32AB
2 . 41±0 . 18AB

ND
3.25±0.90
2.82±0 . 236
2. 29±0 .11AB
2.56±0.33AB

ND
3. 4 0±0 . 24
3. 72±0. 51
4.11±0.01
3 .87±0.05

3 .4 3±o.osct
3. 62 ±0. 07
3.96±0 . 29
4 . 03 ±0. 01
4.11±0.44

IgG producing

0
3
6
9
18

2.94±0.3ldB
3.52±0.25dAB
2 . 97±0. 1 7dAB
2. 94±0 . 52 dAB
1.35±0 . 22AB

ND
3.80±0.51cdAB
3 . 07±0. 33dAB
2. 58±0. 02dAB
1 . 67 ±0 . 18AB

ND
4. 66±0. 26d
4.23±0.38
4 . 42±0.26
3 . 67±0.13

5. 07 ±0. 13d
4.99±0.11
4.39±0.3 5
4.63±0.30
4.23±0.08

IgM producing

0
3
6
9
18

3 . 1 6±0 . 22 cd
3. 30±0 . 21 cdAB
2. 26±0 . 27dAB
1. 32±0. 93AB
o.oo±o.ooAB

ND
2. 98±0. 95dAB
2.08±0.33dAB
1. 97±0 .lJdAB
O.OO±O.OOAB

ND
5 .15±0. 07bcd
3. 7 6±0. 15
3.65±0.35
2.53±0.09

4 . 65±1 . 12
s.89±0.55bcct
4.01±0.21
3.67±0.19
3.12±0.32
U1

w

TABLE 2 (continued)

IgA producing

Macrophage

0
3
6
9
18

1 . 92±0.37d
2. 4 0±0. 07bCdAB
1 . 2 8±0 . 0 1dAB
0. 95±0 . 42dAB
0. 00±0. 00 118

NO

NO

2. 0 9±0. 10bCdAB
1. 22 ±0 .17AB
0 . 84 ±0 . 50 118
o . 51±0 . 02 118

3 .15±0 .18bcB
2.23 ±0 . 18
2 .24±0 .06
2.71 ±0 . 01

0
3
6
9
18

1. 66±0 . 00b
1.74 ±0.05b
0 . 83 ±0.26d
1. 2 9±0. o9d
2 . 15±0.04

2 . 01±0. 61bAB
1 . 03 ±0.22d
1.23±0.06
1 . 84±0.04

NO

NO

1. 09±0 . 11
0.93±0 . 04
1. 19±0 . 13
l. 57 ±0. 01

3 . 39±0.81b
3. 98±0. 23bCd
2.20 ±0.29
2.37±0.60
2. 84±0. 11
l. 69±0 . 2 qb
1.09±0 . 05
0 . 84±0.26d
1.17±0 . 16
1 . 50 ±0.45

*Responses e xpressed as the square root of the absolute number± standard deviation .
a signi f icant when compared with day 3 in the same group (P<O . OS).

b signi f icant
c signi f ica nt
d significant
A sign i ficant
B significa n t

§ not done.

when compared with day 6 in the same group (P<O.OS).
when compared with day 9 i n the same group (P<O.OS).
when compared with day 18 in the same group (P<O.OS).
when compared on the same day to group 3 (P<0 . 05 ) .
when compared on the same day to group 4 (P<0.05 ) .
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very similar throughout the experiment .

Conversely, in

i nfected mice (group 3 ) , the absolute number of B cells
(expressing IgG, IgM, and IgA receptors) varied significantly (P<0.05) when kill dates were compared.

Lymphocytes

with IgG receptors were significantly higher (P<0 . 05) on
day 3 than on day 18 .

The levels of lymphocytes bearing

IgM receptors we r e significantly higher (P<0.05) on day 3
than on days 6, 9, and 18.

Similar ly , IgA levels were

significantly higher (P<0.05) on day 3 than o n days 6 and
9.

These trends seen in lymphocytes (expressing IgG, IgM,

and IgA receptors) within the spleens of c . parvum-infected
mice were also seen in the normal mice (Table 2).
Comparative
cytes

within

effect

treatment

of

DEX

groups.

on

splenic

lympho -

Mice treated with DEX

(group 1) for 3 consecutive days showed a significant
decrease (P<0.05 ) in the absolute number of cells bearing
IgG markers when compared to nonimmunosuppressed mice in
group 4 .

After 6 days of daily DEX treatment, splenic IgG

lymphocytes were consistently less than the nonimmunosuppressed mice.

Both IgM (P<0 . 05) and IgA (P<0 . 05) levels

were significantly decreased in the spleens o f mice that
received DEX for 6 consecutive days.

The IgM, IgG, and IgA

decreases seen in the spleens of DEX-treated animals were
consistently lower than in nonimmunosuppressed mice for the
duration of the exp eriment.

When comparing groups within a
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FIG . 11. Effe ct of dexamethasone a nd Crypto sporidium parvum on the splenic CD4+ to CDS+
lymphocyte ratio. Data are presented as the mean
CD4+ to CDS+ c e ll ratio. Error bars indicate
standard deviations of the mean.

given date, DEX did not significantly affect CDS+ T cells
within the spleen.

However, after 3 days of treatment, the

number of CD4+ lymphocytes were significantly less (P<0.05)
than in normal mice.

After the initial de crease, the

sple n ic CD4+ cells of immunosuppressed mice remained fairly
constant throughout the experiment (Tabl e 2).

Furthermore ,

the CD4+ to CDS+ lymphocyte ratio was dec reased in the
spleens of mice treated with DEX when compared to the
noni mmunosuppressed mice (Fig. 11).

An isolated incidence

on day 3 was seen when the splenic M0 of mice in group 2
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were compared to the nonimmunosuppressed mice in groups 3
and 4.

This significant increase in the absolute number of

M0 may be due to an artifact associated with the sample,
because no signifi cance was seen between mice in group 1
and groups 3 and 4 (Table 2).
Comparative

effect

lymphocytes over time .

of

DEX

exposure

on

splenic

When the effects of DEX were

observed over time, it was evident that the absolute number
of B lymphocytes decreased.

After 21 days of immunosup-

pression (day 18 o f the experiment), the mi ce treated with
DEX wer e nearly depleted of splenic IgG, IgM, and IgAbearing cells.

Although no trends were evident , there were

significant differences in the absolute numbers of splenic
leucocytes expressing CD4+, CDS+, and M0 recept ors (Table
2).
Comparative
lymphocytes

effect

within

of

C.

treatment

parvum

groups .

on

intestinal

When compared to

mice in group 4, c . parvum had no significant effect on the
percent age of lymphocytes in the PP of infected mice that
were killed 3, 6, 9, and 18 days after the experiment
began.

Similarly, no significant effect of c. parvum was

evident between mice in group 1 and mice i n group 2 that
were killed on days 3, 6, and 9 o f the experiment (Table
3).
Comparative
intestinal

effect

lymphocytes

of
over

C.

parvum

time.

exposure

on

Cryptosporidial

TABLE 3.

Phenotypic profiles of lymphocytes• in the Peyer's patche s o f
Cr yptosporidium parvum- infected and control mice

Cell Type

Da y

CDS+

0

3
6
9

18
CD4+

0

3
6

9

18
IgG producing

0

3
6
9

18
IgM producing

0

3
6
9

18

g rou p 1

group 2

3. 39±0 . 10
No§
4 .86±0 . 87
3 . 52 ±0 . 50
4. 52 ±1. 10AB 3. 64±0 . 68AB
4 . 4 1±0 . 2 4AB 3.93±0 . 27AB
NO

3 . 3 9±0 . 10
4.58±0 . 15
5.43±1.04
5.51±0.45
NO

7. 28±0 . 19a
7.40±1.19a
5. 4 3±0. 07
6.18±0.86
NO

7 . 17±0 . 25
4 . 41±1 . 7 6
1 . 80±2 . 55
3.67±1.45
NO

NO
NO

4.04 ±0 . 61
4.63±0 . 38
5.26±0 . 81
NO
NO

6 . 13±1.33
5.98±0.71
5 . 82±0.61
NO
NO

5.24±0.34
5.71±0 . 87
3. 76±1. 32
NO

group 3

group 4

NO

2.12±0.17
3 . 52 ±0.5oabc
1 . 87 ±0.19
2.34 ±0.15
2.44 ±0.29

3 . 38±0 . 31bc
1.98±0.37
2 . 24±0.00
2.55 ±0.14
NO

5. 24±1. 42
4.80±0 . 96
5 . 19±0. 41
4.69±0.15
NO

7.94±0.27b
6.62±0.64
6 . 36±0.06
6.40±0.11
NO

5. 61±1. 77
6.97±0.91
5 . 37±0.66
5.25±0.94

3.94±0.09
5 . 36±1.58
4.51±0.55
4.99±0.43
4.85±0.07
7.55±0.09
7.33±0.77
6.70±0.53
6.16±0.12
6 . 20±0.29
7 . 18±0.15
3.87±2.65
6.28 ±0.21
5.25±0.94
6.07±0.47

U1
00

TABLE 3 (continued)
IgA producing

0
3
6
9
18

6.56±o.ooab
5. 19±2. 05ab
1.83±0.58
2.52±1.12
ND

ND
3.04±4.30
1.87±0 . 19
0.71±1.00
ND

ND
6.50±1.85
2.00±0 . 00
4.18±0.25
4.39±0.73

6.32±0 .lla
4 . 58±1.00
2.55±0 . 14
4.11±0.52
4.9 0±0.00

Macrophage

0
3
6
9
18

1.00±0 . 00
1. 00±0. 00
1.21±0 . 295
1.21±0.295
ND

ND
2.03±0.87
1.00±0.00
1.00±0.00
ND

ND
1 . 21±0.29
0.50±0.71
0.50±0.71
0.00±0.00

1.oo±o.ooab
1.oo±o.ooab
0 . 00±0.00
0.00±0.00
0.00±0.00

*Responses are expressed as the square root of the mean cell percentage

a significant when compared with day 6 in the same group (P<0.05).
b significant when compared with day 9 in the same group (P<O.OS).
c significant when compared with day 18 in the same group (P<O.OS).
A significant when compared on the same day to group 3 (P<0.05).
8 significant when compared on the same day to group 4 {P<0.05).
§ not done.

±

standard deviation.
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infections in immunosuppressed mice (group 2) did not
affect the lymphocytes within the PP when days 3, 6 , and 9
were compared.

Mi ce within group 3 showed a significant

difference (P<0.05 ) in IgG and CDS + lymphocytes.

However,

these statistical differences between days 3 , 6, and 9 were
also seen in the normal mice.

This obs ervati on suggests

experimental variation rather than an immunological response to the parasite.

Moreover, CD4 +, M0,

IgM, and IgA-

recepto r bearing leucocytes within the PP showed no detectable response to cryptosporidial infections when days
3 , 6 , 9, and 1S were compared (Table 3).
Comparative
c ytes

within

effect

treatment

of

DEX

on

intestinal

lympho -

When compared to

groupe.

nonimmunosuppr essed mice, mice treated with DEX for 9 or 12
days had significantly higher levels (P<0 . 05l of and nearly
a two-fold increase of CDS+ lymphocytes in the PP.
patch lymphocytes expressing IgG,

Peyer's

IgM, IgA, and CD4+

receptors showed no detectable response to DEX 3, 6, 9, and
12 days of treatment (Table 3).

Mo reover, DEX treatment

was associate d with a lower CD4+ to CDS + cell rati o within
the PP when compared to the nonimmunosuppressed mice (Fig.
12) .
Comparative
nal

effect

of

lymphocytes over time.

DEX

exposure

on

intesti -

Immunoglobulin G re ceptor-

bearing B cel ls within the PP of mice in group 1 decreased
significantly (P<0 . 05) during the first 6 days following
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FIG . 12. Effect of dexamethasone and Cryptosporidium parvum on the CD4 + to CDS+ lymphocyte
ratio in murine Peyer•s patches . Data are shown
as the mean CD4+ to CDS+ cell ratio. Error bars
indicate standard deviations of the mean.

immunosuppression.

After this initial decrease, cells

expressing IgG receptors remained contant f or the duration
of the experiment.

Similarly, cells bearing IgA receptors

decreased signif icantly in these mice du ri ng the 12 days of
DEX treatment (P<0.051.

When compa ring dates within a

group, DEX failed to affect cells (bearing CDS+, CD4+, IgM,
and M0 receptor s) within the PP (Table 31.
Correlation

between

shedding intensities .

lymphocytes

and

oocyst

No strong l inea r correlation

could be drawn between the number of leucocytes (atta ined
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fr o m flow cytometric ana lysis ) and the intensity or durati o n of fecal oocyst shedding.

A weak positive correlatio n

wa s seen between oocyst shedding and the percentage of IgM
bearing lymphocytes in the PP of immunosuppressed and
nonimmunosupp ressed mice (0.60 and 0 .5S, respectively).
Similarly, a weak correlation could be drawn between the
oocyst shedding and the M0 within the spleen (Table 4).

TABLE 4. Correlation coefficient r drawn between
lymphocytes and oocyst shedding intensities
Tissue

Cell Type

Group 2

Group 3

Spleen

CDS+
CD4+
M0
IgG producing
IgM producing
IgA producing

-0 .1 2
-0.01
-0.51
-0 . 05
-0.19
-0.25

-0.07
-0.32
-0 .4 5
0.36
0 . 40
-0 . 04

pp

CDS+
CD4+
M0
IgG producing
IgM producing
IgA producing

-0.12
-0.01
-0.40
0 . 02
0. 60
-0.24

0 . 06
0.02
0.45
0.43
0.5S

PP
M0

Peyer' s patches;
macrophages

-o.os
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DISCUSSION

Immunohistochemistry
To accomplish the goals of this study, considerable
time and ef fort was spent developing a workable immunohistochemical technique.

Initial ly, the ABC method was

attempted on paraffi n-embedded sec ti ons because o f its
superior staining sensitivity, which results from amplification of the antigen-antibody reaction (72).

To enhance

staining intensity and / or eliminate nonspecific binding,
several alterations of the protocol were tried.

Inasmuch

as none of the modifications gave a satisfactory result ,
immunofluorescence techniques were attemp t ed.
Direct and indirect fluorescent ant ibody techniques
were applied to paraffin-embedded tissue sections.

Due to

great variation in sensitivities of antigens to different
physical and chemical conditions, various fixation methods
were tried prior to paraffinization.

Regardless of the

fixation method or modification to the protocol, M0 and T
lymphocytes (C D4+, CDS+, and TTotall showed no immunoreactivi ty.

Appar ently the fixatives (formalin, B-5, Histo-

choice, and Bouin's) failed to preserve t he antigenic
determinants of the M0 and T lymphocytes .
The capacity of B lymphocytes to react with FITClabeled antibody was preserved by Bouin' s solution.

This

allowed for the determination of the effects of DEX on the
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humoral response in the spleen and intestinal lamina
propria.

The results and discussion generated from immuno-

histochemical techniques are of academic interest because
the objective o f this research was accomplished by fl ow
cytometry that elucida ted both c ell-mediated and humoral
immune responses.

Nonetheless, preliminary data and

observa ti ons fr om immunohistochemical techniques are
prese nted.

Immunohistochemica l evaluation o f paraffin-

embedded sections showed that DEX reduced the number of
lymphocytes expressing IgA receptors within the spleen and
intestinal lamina propria.

This suggests that these

lymphocytes may play a role in immunity to cryptosporidi os is .

Presumably this cou ld occ ur because secretory anti -

bodies present in the intestines can help eliminate C.
parvum by mediating biological processes ( 111 ) .

Moreover ,

IgA can be transported across epithelial cells o f the
intesti ne from the basal to the a pical surface o f these
cells by transcytosis (2) .

Accordingly, it is plausible

t hat dimeric IgA might reach the basal membrane of attached
cryp t osporidia and hinder parasite feeding and development.
Results produced from this preliminary study varied somewhat from those obtained by flow cytometric analyses.
Immunohist ochemical evaluations comparing lymphocytes in C.
parvum-infected mice to DEX-treated mice with cryptosporid iosis showed that within the spleen and intestinal lamina
propria, IgA was the on ly isotype affected by DEX.

Because
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chese resulcs were obcained fr om a preliminary scudy wich a
few animals, ic is difficulc co in fer why lymphocyces
express ing IgG and IgM markers were noc significanc ly
reduced in DEX-creaced mice .

To offer claricy co chese

findings, I am performing immunohiscochemical cechniques on
cermina l ilea of normal and immunosuppressed mice wich
crypcosporidiosis.

Analysis by flow cycomecry showed chac

B lymphocyces (expressing IgG, IgM, and IgA recepcors l
wichin che spleen. but noc che PP, were affecced by DEX.
Any o ne o f che following may concribuce co che difference
in che resulcs of immunohiscochemical evaluacions and flow
cyt omecric an alyses: l l

The age of the mice used in the

preliminary study (immunohiscochemiscry ) were 4 weeks older
chan chose mice used for fl ow cytomecry; 2 )

The ani mal

numbers in che study ucilizing immunohistochemistry had
chree mice pe r creatmenc group , whereas che resulcs gener aced from flow cycomecry had eighc mice per group; and 3)
The duration of immunosuppression of mice evaluaced by che
immunohistochemical cechnique were treated wich DEX f or 20
days, whereas those used for flow cytomecry were created
wich DEX for 12 days.
Infection

dynamics

Oocysc shedding pacterns seen in chis experiment were
not unlike those previ ous ly observed in normal and DEXcreaced adulc C57BL /6N mice chac were infecced wich C .
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parvum (114 ) .

Infected mice that were not immunosuppressed

quic kly cleared the infection, whereas DEX-treated mice
shed oocysts in fluctuant amounts until the experiment was
terminated .

The fluctuation of shedding intensities

observed in this experiment and by others is possibly due
to the inherent variation in sample preparation or to the
course of autoinfection by thin-walled oocysts and merozoites.

The trends o f parasite coloni zation in the ileum

and oocyst shedding were very similar with the exception of
day 3.

On day 3, oocyst shedding was markedly lower than

ileal colonization by C. parvum .

These observations are

reasonable because the majority of the parasites may have
had insufficient time to complete gametogony and formation
of oocysts .

Taghi-Kilani et al. (1990) report that no

correlation could be drawn between the intensity of Crypcosporidium-specific responses and the severity or

duratio~

of cryptosporidi osis in neonatal BALB/c mice, although
these mice exhibited a good IgM and IgG serum antibody
response (128) . Similar results were produced in this study
in t hat no st r ong linear correlation was evident between
the presence of lymphocytes in the tissu es (spleen and PP)
and the intensity of oocyst shedding.

I believe that these

observa tions reflect the insignificance between the cell
numbers o f infected and uninfected mice rather than suggesting that in vivo immune responses play a minor role in
thwarting the development of C. parvum.
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Even though cryptosporidial infections did not significantly affect splenic weights, mice in group 3 had an
increase in splenic weights as the experiment progressed.
This suggests that immunocompetent mice are responding to
C. parvum while infected immunosuppressed mice do not.

Dexamethasone rapidly reduced the weight and size of the
spleen and PP.

After 3 consecutive days of treatment with

DEX (day 0 of the experiment), the mean spleen weight was
approximately one half that of the nonimmunosuppressed
mice .

This reduction is profound not only because of how

rapidly it occurred, but also because the spleen weights
remained constant after the initial decrease despite
continuous administration of DEX.

The differences in

spleen weight were taken into consideration by using the
absolute number (cell percentage multiplied by the spleen
weight) in the statistical analysis.
reduced the size of the PP.

Additionally, DEX

One to 4 PP could be identi-

fied and harvested from the small intestine of an immunosuppressed mouse with the aid of a dissecting microscope.
·However, the unaided eye could see 6 to 8 PP on the small
int estine of a nonimmunosuppressed mouse.

Because DEX

dramatically reduced the size of the lymphoid tissues, it
was necessary to pool the tissues of four mice.

Twenty-one

days after immunosuppression began, it was impossible to
collect the PP for flow cytometric analysis because they

68
were inconspicuous o r absent (even with the aid o f a
dissecting microscope ).
In addition t o inducing a lymphopen ia and decreasing
the splenic weight, glucocorticoids affect carbohydrate
metabolism by promoti ng gluconeogenesis and liver glycogen
deposit and elevating blood glucose levels (129).

Addi-

tionally, DEX inhibits insulin release by the 8-cells of
the pancreatic i slets (76), thus inhib iting the entry o f
glucose into cells. glycolysis, and production of ATP.
These physiolog ical events may explain the weight loss
obse rved in mice treated with DEX (groups 1 and 2), because
when the production and hydroly s is of ATP are affected,
metabo li c reactions, including synthesis of nucleic acids
and proteins , are hampered.
Flow

cytometric

analysis

All strains o f laboratory mice (inbred, out bred,
immunodeficient, and germ-free) tested to date are difficu lt to infect with C. parvum once they are more than 3
weeks of age (3 4, 63, 123).

These observations suggest

that genetically based as well as age-re lated factors
(immu ne status, gut physiology, or microflora) may be
responsible f o r determining susceptibility o r resistance to
C. parvum in mice (34) .

Therefore, an immunocompromised

animal model for chronic cryptosporidiosi s was necessary to
accomplish the goals o f this study.

The small animal model
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that was used in the present study was devel oped by
Rasmussen and Healey (114) .

These authors show that

C57BL / 6N mice immunosuppressed by intraperitoneal injections of DEX at a dosage of 125
to

~g

per day are susceptible

c. parvum and developed chronic infections which per-

sists at least 10 weeks.

This immunocompromised laboratory

animal model did not substantiate the immune response to C.
parvum, but rather discerned the immunological defects
which allow for the development of chronic infections.
Therefore , the absence of statistical significance (in the
number of ce lls expressing CD4+ , CDS+, IgG, IgM, IgA, and
M0 receptors) between mice in group 1 and group 2 was
anticipated .
Nonspecific immunity and the role o f M0 were discussed
earlier in this thesis .

In the present study there was no

statistical difference in the numbers of M0 when groups 3
and 4 were compa r ed.

Moreover, flow cytometry yielded

inconclusive data on the effects of DEX on M0.

These

ambiguities are likely due to the paucity of M0 in the
spleen and PP.

Future research investigating the effects

of DEX on M0 should consider in vitro techniques with
peritoneal M0 to overcome this limitation.
The present study demonstrated that mice treated with
DEX had significantly fewer CD4+, IgG, IgM, and IgA receptor-bearing lymphocytes within their spleens compared with
nonimmunosuppressed mice.

This observat ion implicates the
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lymphocyte subpopulations that are responsible f or arresting the development of C . parvum.

Initially, it is tempt-

ing to dismiss the import ance o f Ig-bearing cells because
the parasite is intracellular and ot hers have shown that
antibod ies alone cannot e liminate C. parvum from the
infected mucosa (62 , 98, 128) .

Before the role of B

lymphocytes is dismissed, the complex interaction between B
and T lymphocytes needs co be co nsidered.

A B cell can

activate a CD4+ cell by caking up antigen, c onvert ing it co
a f orm that is recog nizable co the T lymphocyte, and then
presenting it t o the T cell.

After antigenic activation,

the T lymphocyte is stimulated to release lymphokines,
whi ch in turn promo te stimulation of other lymphocytes and
M0.

Moreover, T lymphocy tes (C D4+ ) are requi red f or most B

lymphocytes to respond co a ntigen .

Without any further

description o f the immunologica l response, one can see that
if a lymphocyt e population is affected by DEX, it has the
potential o f affecting all lymphocytes associated with the
network.

In other words, the humoral immune response may

not directly affect C. parvum , but the paucity of B cells
may affect the ability o f the ce ll-mediated immune response
t o control the infe ct i on.

These findings are consistent

with the hypothesis that a T lymphocyte is involved in
recovery from cryptosporidial infection and that recovery
is associated with both cellular and humoral immune responses co cryptosporidial antigens (34).

The importance
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of lymphocytes (bearing CD4+ receptors) in immunity to

c.

parvum is demonstrated in this study by the decrease of
splenic helper T lymphocytes and by the decreased CD4+ to
CD8+ cell ratios.

Unfortunately, the fundamental physical

or chemical processes (mediated by T l ymphocytes) that are
responsible for parasite killing remain unclear (92).
Nonetheless , it is reasonable to speculate that the elimi nation of C. parvum by lymphocytes bearing CD4+ receptors
may be due to the secretion of lymphokines and thus activation of M0, B and T lymphocytes .
The increase of CD8+ lymphocytes in the PP of DEXtreated mice suggests that these cytotoxic cells play a
role in immunity to cryptosporidiosis.

Harp et al.

(59 ) show that in mild cryptosporidial infections,

(1988)

c.

parvum colonizes on or near the dome epithelium of the PP.
This parasitic colonization may be facilitated by the CD8+
lymphocytes suppressing the intestinal immunological
response .

Conceptually, this could occur if the CD8+ cells

kill other T lymphocytes (or B cells) bearing specific
idiotypic determinants related to antigen recognition.
Another way in which CD8+ lymphocytes could suppress immune
responses to C. parvum would be by killing the active
antigen presenting cells, thus removing the stimulus before
an immune response could be generated (50) .

Alternatively,

the presence of parasites juxapposed to the PP may be
explained by the fact that T lymphocytes expressing CD8+
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receptors

sec ret ~

substances that facilitates parasite

colonization .
Other studies have addressed the role of CDS+ cells in
immunity to cryptosporidiosis.

Adult BALB/c mice depleted

of CD8+ lymphocytes through in vivo treatment with Mab did
not develop persistent infections (13Sl.

Aguirre et al.

(1994) show that major histocompatibility complex (MHC)
class I-deficient mice (lacking functional CD8+ cells)
infected at 5 to 6 weeks of age were no more susceptible to
C. parvum infection than age-matched controls (1).

The

results of these studies do not support the hypothesis that
CDS+ cells play a r ole in protective immunity to cryptosporidiosis.
al.

However, the present study and Rasmussen et

(115) show that CDS + lymphocytes are increased in

immunosu ppressed mice that are infected with C. parvum.
Boher et al.

(1994) show that after infection of neonatal

mice with c. parvum, ileal PP show a predominant CD8+ T
cell response (18) .

Additionally, McDonald et al . (1994)

show that CD8+ cells appear to be involved in resistance to
· primary and secondary cryptosporidial infections (92).
Future studies perf orming functional assays on CDS+ cells
harvested fr om animals infected with C. parvum may offer
clarity to these equivocal results.
One of the most striking results of the present study
was the lack of any statistical significance in the number
of lymphocytes (expressing CD4+, CDS+, IgG, IgM, and IgA
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receptors) between nonimmunosuppressed mice infected with

c.

parvum and the mice in group 4.

The results appear to

contradict those studies that show B and T lymphocytes to
be responsible for eliminating C. parvum fr om the intestinal mucosa 11 , 14, 15, 18, 22, 23, 34, 37, 44, 45, 52, 56,
57, 62, 70, 78-80, 84, 85, 91, 94, 95, 99, 103, 106, 128,
134, 137, 139, 140, 144, 146 ) .

The apparent discrepency

between the results of this study and previously published
work may be explained by antibody specificities.

Previous

studies detecting serum, duodenal, and fecal antibodies
used C . parvum antigens to probe for parasite-specific
antibodies, whereas the antibodies against mouse irnrnunocy tes used in this study were not c . parvum-specific.
Therefore, the evoked

c. parvum-specific immune response is

not significant above the indigenous BandT lymphocytes.
This explanation is supported by other studies that assayed
for total lymphocyte levels in humans and mice with cryptosporidiosis.

Splenic CD4+ 1115), CDS+, TTotal, and BTotal

lymphocytes (37, 115 ) from infected mice were comparable to
controls .

Likewise, total IgG and IgM antibody levels in

serum, stool, and duodenal fluid from infected children

ar~

not sta tistically different from control subjects (80).
Alternatively, the discrepancy between the results of the
present study and previously published work may be explained by animal numbers.

Perhaps significance would be

present between infected and normal mice if this experiment
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was repeated wit h more animals per group.

Increasing

animal numbers would result in more repetitions, increased
degrees of freedom, and decreased variance.

Consequently,

a greater possibility of statistical validity may become
apparen t.

Alternatively, severity and length of infection

may be a factor.

Many of the researchers that demonstrated

coproantibodi es and seroconversion used specimens from
human or large domestic animals that had severe infections
and cryptosporidial diarrhea (22, 23, 70, 80, 99, 137, 139,
140, 146).

Because tissues were harvested, this study was

limited to small laboratory animals.

The immunocompetent

adult female C57BL/6N mice used in this study developed a
mild infection without diarrhea for 6 days, after which the
infection was cleared.

Apparently , the length and inten-

sity of the cryptosporidial infections were not sufficient
to elicit a detectable immunological response within the
spleen or PP.
Conclusions

This study was undertaken to quantify suqpopulations
o f lymphoid cells present in the spleen and small intestine
(lamina propria and PP ) of normal and immunosuppressed
adu lt C57BL/ 6N mice that were either noninfected or infected with C. parvum.

The following conclus i ons may be drawn

from this research: 1) The evoked C. parvum-specific immune
response is not significant above the indigenous B and T
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lymphocy~es

present in the spleen and PP; 2) DEX, a

syn~he~ic cor ti cos~eroid,

significantly reduced splenic

lymphocytes expressing CD4+, IgG, IgM, and IgA receptors.
This differential effect explains why only immunosuppressed
mice were capable of maintaining infections with
3) CDS+ cells within the PP may play a role in
C. parvum by suppression or
lymphocy~es

idiotypic

and

parvum;

immuni~y

killing of

to

o~her

cells bearing specific

an~igen presen~ing

determinan~s;

and 4) Immunohistochemical evalua-

tion of paraffin-embedded
the spleen and

cy~otoxic

c.

in~es~inal

~issues

suggests that IgA (within

lamina propria) may play a role

in the protective immune response to cryptospordial infection .
Las~ly,

I believe

~hat

~hese

preliminary findings will

serve as a first step toward developing
therapies for use in

patien~s

tosporidial infections.
emerge from future

immun omodula~ion

with debili tating cryp-

Moreover, valuabl e data should

inves~igations

that address specific

immune respons es within lymphoid cells associated
intes~ine

and systemi c compartment .

wi~h

the
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